Hyperbaric Oxygen Therapy for Spinal Cord Injury: Current Evidence

Important: Hyperbaric oxygen therapy is not FDA-approved for spinal cord injury. This is an investigational use. Evidence is preliminary and comes largely from animal studies. Insurance will not cover HBOT for this condition. All costs are out-of-pocket.

A spinal cord injury changes what the body can do below the level of the damage, and families often start researching every possible avenue within days of the diagnosis. Hyperbaric oxygen therapy turns up in those searches, sometimes alongside promotional clinic pages that promise more than the research supports. This page lays out what the studies actually found.

If someone has a suspected acute spinal injury, call 911. Do not move the person unless they are in immediate danger. Acute spinal trauma is managed by emergency and surgical teams, not by HBOT.

How HBOT Is Proposed to Work After Spinal Cord Injury

A spinal cord injury happens in two phases. The primary injury is the mechanical damage from the original trauma. Over the hours and days that follow, a secondary cascade sets in: swelling, reduced blood flow, falling oxygen levels in the tissue, inflammation, and the death of cells that survived the initial impact. That secondary injury can extend the damage beyond the original site.

The argument for HBOT targets that second phase. By pressurizing the body and raising the amount of oxygen dissolved in plasma, HBOT can push oxygen into tissue even where circulation is impaired. The hypothesis is that this extra oxygen may limit secondary injury and support neurons that are damaged but not yet dead. For more on the underlying mechanism, see the how HBOT works guide.

That is a hypothesis, not a settled fact. Most of the support for it comes from laboratory and animal work rather than human trials.

What the Research Has Found

The honest summary is that the evidence is preliminary and the strongest signals are in animals.

Falavigna et al. (2009) published a systematic review in Coluna/Columna that examined 11 studies spanning 1963 to 2009, nine of them animal experiments and two in humans. The animal studies were encouraging, showing recovery of locomotor function and reduced cell death, with the clearest effect when treatment began within about 30 minutes of injury. The two human trials conflicted: one reported improvement in spinal function scores, the other found no significant difference between groups. The authors concluded that further studies are needed to define any role for HBOT in spinal cord injury.

Asamoto et al. (2000) reported a retrospective comparison in Spinal Cord of 34 patients with acute traumatic cervical injuries, half treated with HBOT and half not. The treated group improved by a mean of 75.2 percent on a cervical spine neurological scale, compared with 65.1 percent in the untreated group (PMID: 11035474). The difference was modest, the study was retrospective rather than randomized, and the sample was small, so the result cannot be read as proof.

The most recent pooled analysis is Huang et al. (2021), a meta-analysis in Journal of Back and Musculoskeletal Rehabilitation of 11 randomized controlled trials with 875 patients. It reported improvements in motor function, sensory function, daily activities, and psychological measures in the HBOT groups (PMID: 33935063). That sounds favorable, but the same authors cautioned that the included trials were small and of low methodological quality, and they called for larger high-quality trials before drawing conclusions. Reading a positive headline number without that caveat would misrepresent the strength of the evidence.

Put the three together and the pattern is consistent. Animal data is supportive, human data is limited and mixed, and no large rigorous trial has settled the question.

Timing: Acute Versus Chronic Injury

The animal research points toward earlier being better, with some models showing benefit only when oxygen was delivered within minutes of the injury. That window is difficult to translate to real-world care, where a person with acute spinal trauma is being stabilized, imaged, and often taken to surgery.

For chronic injury, months or years out, the rationale shifts toward supporting tissue that remains partly viable and encouraging neuroplasticity, the nervous system’s capacity to reorganize. Human evidence in the chronic setting is thinner still. No standard treatment window, pressure, or session count has been established for either acute or chronic spinal cord injury.

What HBOT Will Not Do

There is no evidence that HBOT reverses established paralysis or restores function that has been permanently lost. It is not a cure for spinal cord injury, and any clinic presenting it that way is moving well beyond the research.

HBOT also does not replace standard spinal cord injury care. Surgical stabilization, careful management in the acute phase, and a long course of physical, occupational, and other rehabilitation therapies are the backbone of recovery, and they have far more evidence behind them than HBOT does. Pursuing an investigational option should never mean delaying or skipping that care. Because this is an off-label use, the off-label HBOT guide is worth reading before spending money on it.

Cost and Coverage

Insurance will not cover HBOT for spinal cord injury, because it is not a recognized indication. That means the full cost falls on the patient.

Sessions typically run $250 to $450 each, and rates change annually, so verify current pricing with the facility’s billing team. Research protocols have used a wide range of session counts, and no standard course exists for this use, so a full out-of-pocket commitment can be substantial. Ask your physiatrist or neurologist to review the current evidence with you before deciding whether that cost is reasonable for your situation.

Frequently Asked Questions

Will insurance cover HBOT for spinal cord injury? No. It is not FDA-approved for this use, so insurance will not cover it. All costs are out-of-pocket.

Can HBOT help years after the injury? Human evidence for chronic spinal cord injury is limited and inconsistent. The theory involves supporting partly viable tissue and neuroplasticity, but no trial has established benefit in that setting. Ask your care team.

Is HBOT safe for someone with a spinal cord injury? HBOT is generally considered safe when delivered in an accredited facility by trained staff, but it is not appropriate for everyone. A physician needs to review the individual’s full medical history, including respiratory and bladder management, before any decision.

Should HBOT replace rehabilitation? No. Rehabilitation has strong evidence and is the core of recovery. HBOT does not replace it and should not delay it.

References

Falavigna, A. et al. (2009). Effects of hyperbaric oxygen therapy after spinal cord injury: systematic review. Coluna/Columna, 8(3).

Asamoto, S. et al. (2000). Hyperbaric oxygen (HBO) therapy for acute traumatic cervical spinal cord injury. Spinal Cord. PMID: 11035474. https://pubmed.ncbi.nlm.nih.gov/11035474/

Huang, L. et al. (2021). Effects of hyperbaric oxygen therapy on patients with spinal cord injury: A systematic review and meta-analysis of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation, 34(6), 905-913. PMID: 33935063. https://pubmed.ncbi.nlm.nih.gov/33935063/

Browse every condition on the conditions hub. For related investigational brain and nerve topics, see the stroke recovery page, the TBI and concussion page, and the multiple sclerosis page.

Medical Disclaimer: This page is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Hyperbaric oxygen therapy for spinal cord injury is investigational and not FDA-approved. Always consult a qualified healthcare provider before pursuing any medical treatment. This site does not establish a doctor-patient relationship.